tiprankstipranks
Trending News
More News >
Brainstorm Cell Therapeutics (BCLI)
OTHER OTC:BCLI
US Market

Brainstorm Cell Therapeutics (BCLI) Financial Statements

Compare
570 Followers

Brainstorm Cell Therapeutics Financial Overview

Brainstorm Cell Therapeutics's market cap is currently $6.40M. The company's EPS TTM is $-0.19; its P/E ratio is -0.40; Brainstorm Cell Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 849.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 849.00K$ -265.00K$ -285.00K$ -260.00K$ -219.00K
Operating Income$ -11.69M$ -21.44M$ -24.82M$ -24.54M$ -31.68M
EBITDA$ -11.31M$ -16.93M$ -23.99M$ -24.28M$ -31.46M
Net Income$ 11.62M$ -17.19M$ -24.28M$ -24.46M$ -31.81M
Balance Sheet
Cash & Short-Term Investments$ 187.00K$ 1.30M$ 2.98M$ 22.09M$ 41.94M
Total Assets$ 1.83M$ 4.21M$ 8.45M$ 29.28M$ 51.26M
Total Debt$ 720.00K$ 1.27M$ 4.09M$ 5.08M$ 7.22M
Net Debt$ 533.00K$ -25.00K$ 3.32M$ -13.78M$ -30.61M
Total Liabilities$ 9.60M$ 9.07M$ 11.47M$ 9.94M$ 15.79M
Stockholders' Equity$ -7.76M$ -4.86M$ -3.02M$ 19.34M$ 35.46M
Cash Flow
Free Cash Flow$ -9.09M$ -20.48M$ -19.35M$ -26.59M$ -35.57M
Operating Cash Flow$ -9.09M$ -20.46M$ -19.32M$ -26.27M$ -35.19M
Investing Cash Flow$ 12.00K$ 2.19M$ 998.00K$ 323.00K$ -4.45M
Financing Cash Flow$ 7.97M$ 18.98M$ 238.00K$ 6.97M$ 76.94M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History

Brainstorm Cell Therapeutics Debt to Assets

Brainstorm Cell Therapeutics Cash Flow

Brainstorm Cell Therapeutics Forecast EPS vs Actual EPS